Program at a Glance

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Tuesday March 28

8:00 – 12:00

One Health and Blood Operator Workshop

8:00 – 13:30

AMMI Canada Council Meeting

12:00 – 17:00

AMMI Canada CRN Meeting

12:30 – 17:00

Trainees’ Day

17:00 – 18:00

Trainees’ Day Welcome Reception

17:00 – 19:00

CACMID Board Meeting

18:00 – 19:30

Paladin co-developed accredited learning activity with dinner
Management of complicated Gram-positive infections in adult patients: current treatment challenges, unmet needs, and new treatment options

Wednesday March 29

7:00 – 9:00

Masterclasses
New Tuberculosis Guidelines
Lab Validation and Verification

7:30 – 9:00

Roche Canada co-developed accredited learning activity with breakfast
Part I: Transplant viral load testing for BKV and EBV
Part II: Mycoplasma genitalium infections: A challenge in Canada

9:15 – 11:30

Plenary
Emerging Infectious Diseases in Canada – From Poop to Data to Diagnostics

11:30 – 12:30

Merck Canada co-developed accredited learning activity
Management of Cytomegalovirus (CMV) in transplantation

12:30 – 14:30

Lunch and Exhibit Hall Open

12:30 – 14:30

In-Person Poster Presentations

12:30 – 14:30

AMMI Canada AGM and Sections Meeting

14:45 – 15:45

State of the Art Clinical Lecture
Travel and Refugee Infectious Disease Update 

16:00 – 17:00

GSK co-developed accredited learning activity
Respiratory Syncytial Virus (RSV) in older adults:
The under recognized burden

17:00 – 18:00

Merit and Association Awards Presentations

18:00 – 18:30

Special Lecture
Stanley’s Dream: The Canadian Medical Expedition to Easter Island

18:30 – 20:00

Meet and Greet Welcome Reception
Poster Viewing and Presentations

Thursday March 30

7:00 – 9:00

Masterclasses
Genomics: Impact on IPAC and PH
Optimizing options to end the epidemic: Harnessing the full array of antiretroviral agents for the treatment and prevention of HIV

7:30 – 9:00

Pfizer Canada co-developed accredited learning activity with breakfast
Reduce the Risk: Optimizing care for patients at risk of COVID-19

9:15 – 11:15

Plenary
Antimicrobial Susceptibility Testing Updates: Making Sense of the Breakpoint Alphabet Soup and Rapid AST Options

11:30 – 12:30

Hologic co-developed accredited learning activity
Complementing In Vitro Diagnostics (IVD) molecular testing menu options with Laboratory Developed Tests (LDTs)

12:30 – 14:30

Lunch and Exhibit Hall Open

12:30 – 14:30

In-Person Poster Presentations

12:30 – 14:30

CACMID AGM with special 90th anniversary lecture by Dr. Michael Mulvey

14:45 – 15:45

State of the Art Clinical Lecture
Oral vs. IV Antibiotics: A Tough Pill to Swallow?

16:00 – 17:00

Student Oral Presentations Competition – Session A

16:00 – 17:00

Oral Presentations – Session B

17:15 – 18:15

Case Reports Symposium

18:30 – 20:30

AstraZenca unaccredited learning activity with dinner

18:30 – 22:30

JAMMI Editorial Board Meeting

Friday March 31

6:30 – 8:30

CFID Bug Run

7:00 – 9:00

Masterclasses
How to Build a Research Program
Communication with the Public/ Social Media

7:30 – 9:00

CSL Seqirus co-developed accredited learning activity with breakfast
A critical look at influenza vaccine technologies: From bench to bedside

9:15 – 10:15

State of the Art Clinical Lecture
Fundamentals of laboratory stewardship: essential components and easy wins

10:30 – 11:30

Oral Presentations – Session C

10:30 – 11:30

Oral Presentations – Session D

11:30 – 13:30

Lunch and In-Person Poster Presentations

11:30 – 13:30

CCM AGM

11:30 – 13:30

AMMI Canada Phage Working Group Meeting

12:00 – 13:30

Merck Canada co-developed accredited learning activity with lunch
Pneumococcal vaccines for adults – past, present, and future

12:00 – 13:30

ViiV Healthcare Canada co-developed accredited learning activity with lunch
When RWE reinforce RCT results: Review of the effectiveness and barrier to resistance of DTG/3TC in clinical practice

13:45 – 14:45

State of the Art Clinical Lecture
Nuclear Medicine In Infectious Disease

14:45 – 15:45

Sanofi co-developed accredited learning activity
RSV burden of disease in infants – A need for all infant protection

16:00 – 18:00

Plenary
What’s Hot in Infectious Disease, Medical Microbiology, Stewardship and Infection Control
Co-Developed with Canadian Foundation for Infectious Diseases (CFID)

18:00 – 18:30

Merit, Poster, and Research Awards
Closing Remarks